SciELO - Scientific Electronic Library Online

 
vol.27 número6Afectaciones visuales en pacientes con COVID-19Rol del hiperaldosteronismo primario para el desarrollo de hipertensión arterial índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista de Ciencias Médicas de Pinar del Río

versión On-line ISSN 1561-3194

Resumen

PINTA-RIOFRIO, Mario David; CHECA-HUILCATOMA, Sebastián Alejandro  y  SANCHEZ-SANCHEZ, Javier Estuardo. Therapeutic options in trigeminal neuralgia. Rev Ciencias Médicas [online]. 2023, vol.27, n.6  Epub 01-Nov-2023. ISSN 1561-3194.

Introduction:

the cranial nerve V is responsible for sensation in the face, including the mouth. Trigeminal neuralgia causes sudden intense pain in the face, which can be shooting, shooting or sharp.

Objective:

to describe the therapeutic options in trigeminal neuralgia.

Methods:

a literature review was performed by searching the Scopus and PubMed/MedLine databases for information. Clinical trials and meta-analyses published in the last five years were included.

Results:

both nerve growth factor and brain-derived neurotrophic factor can cause and treat pain. The occurrence of pain is a biological self-defense mechanism; during treatment, the therapeutic effect of neurotrophic factors can be maintained and pain can be reduced.

Conclusions:

based on the results, the classification of trigeminal neuralgia now includes two scientifically based subgroups, idiopathic and classic trigeminal neuralgia. A diagnostic evaluation is necessary in order to offer an adequate treatment.

Palabras clave : TRIGEMINAL NEURALGIA; TRIGEMINAL NERVE; THERAPEUTICS; NERVE GROWTH FACTORS; THERAPEUTIC USES.

        · resumen en Español     · texto en Español     · Español ( pdf )